<DOC>
	<DOCNO>NCT01483183</DOCNO>
	<brief_summary>The purpose Part 1 study determine maximally tolerate dose OPC-108459 patient paroxysmal persistent atrial fibrillation ( AF ) . The purpose Part 2 study determine potential efficacy dose ( ) OPC-108459 treatment paroxysmal persistent atrial fibrillation .</brief_summary>
	<brief_title>Ascending Dose Study OPC-108459 Intravenous Infusions Patients With Paroxysmal Persistent Atrial Fibrillation</brief_title>
	<detailed_description>This trial test pharmacokinetic pharmacodynamic characteristic ascend dos OPC-108459 separate population paroxysmal persistent AF subject . The trial consist two part . Each part evaluate two population subject present cardioversion hospital setting . Cohorts paroxysmal persistent subject may dose increase independently .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Subjects paroxysmal atrial fibrillation ( AF ) ( recent new onset ) subject persistent AF time randomization Subjects hemodynamically stable Subjects low risk thromboembolic potential Subjects willing comply reproductive precaution Subjects : History long QT syndrome , Torsade de Pointes uncorrected QT interval &gt; 450 ms History myocardial infarction within 6 month screen Acute coronary syndrome , angina active myocardial ischemia diagnose ECG , image within 6 month screen History ventricular tachycardia , fibrillation , resuscitate cardiac arrest History clinically significant congenital heart disease Presence severe aortic mitral stenosis , aortic mitral regurgitation , atrial septal defect , condition lead AF Diagnosis heart failure NYHA Class IIIV ejection fraction &lt; 40 % ( Part 1 ) Diagnosis heart failure NYHA Class IV NYHA I , II , III ejection fraction &lt; 35 % ( Part 2 ) Concomitant treatment class I III antiarrhythmic agent unless medication discontinue 5 halflives dose History seizure Diagnosis atrial flutter Diagnosis stroke , TIA ( transient ischemic attack ) , transient neurological deficit within 1 year screen know carotid artery stenosis &gt; 50 % Cardiac surgery within 3 month screen Bradycardia ( &lt; 50 bpm ) sick sinus syndrome , unless control pacemaker Current reversible cause AF WolffParkinsonWhite syndrome Any congenital abnormality , severe valve disease Subjects take another investigational product within 30 day dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Atrial fibrillation</keyword>
	<keyword>Paroxysmal Atrial fibrillation</keyword>
	<keyword>Persistent Atrial fibrillation</keyword>
	<keyword>A-fib</keyword>
</DOC>